Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation-Reference-Cited by-同舟云学术

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

Published:2015-03-20 Issue:5 Volume:61 Page:1485-1494
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Forns Xavier¹,Charlton Michael²,Denning Jill³,McHutchison John G.³,Symonds William T.³,Brainard Diana³,Brandt-Sarif Theo³,Chang Paul³,Kivett Valerie³,Castells Lluís⁴,Prieto Martín⁵,Fontana Robert J.⁶,Baumert Thomas F.⁷,Coilly Audrey⁸,Londoño Maria Carlota¹,Habersetzer François⁷

Affiliation:

1. Liver Unit, IDIBAPS, CIBEREHD, Hospital Clinic, University of Barcelona; Barcelona Spain

2. Intermountain Transplant Center; Murray UT

3. Gilead Sciences, Inc.; Foster City CA

4. Liver Unit-Internal Medicine Department, CIBEREHD; Hospital Universitari Vall Hebron; Barcelona Spain

5. Hepatology Unit, CIBEREHD, Hospital Universitari i Politècnic La Fe; Valencia Spain

6. Department of Internal Medicine; University of Michigan; Ann Arbor MI

7. Hôpitaux Universitaires de Strasbourg; Inserm U 1110 Strasbourg France

8. Centre Hépato-Bilaire, Hôpital Paul Brousse; Inserm UMR-S785 Villejuif France

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. Liver transplantation in the setting of chronic HCV;Terrault;Best Pract Res Clin Gastroenterol,2012

2. Viral hepatitis in liver transplantation;Crespo;Gastroenterology,2012

3. the International Liver Transplantation Society Panel. Report of the first International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C;Wiesner;Liver Transplant,2003

4. Hepatitis C virus kinetics during and immediately after liver transplantation;Garcia-Retortillo;Hepatology,2002

5. Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment, and treatment;Berenguer;J Hepatol,2013

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients;Viruses;2023-08-07

2. Infections in liver transplantation;Viral, Parasitic, Bacterial, and Fungal Infections;2023

3. HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation;Clinics and Research in Hepatology and Gastroenterology;2022-11

4. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review;Hepatology International;2022-09-09

5. Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens;Journal of Clinical Medicine;2022-01-31